Hutch News

Hutch News

Stories tagged 't cell therapy'

When do we say cure?

A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics

July 8, 2016 | By Rachel Tompa / Fred Hutch News Service

An individual patient may not hear the word "cure" on their oncologist's lips, but that doesn't mean the word has no meaning to researchers. It's just that it's very difficult to apply it to an individual person.

View story >

Seattle's life sciences scene in the spotlight

Xconomy forum highlights research in vaccines, organ transplants, big data, more

May 3, 2016 | By Rachel Tompa / Fred Hutch News Service

It was a dizzying round-up of Seattle’s life sciences research and biotech scene, from designer proteins to the looming threat of the Zika virus. This year’s forum was titled “Life Sciences Disruptors,” though Lash and the other speakers didn’t focus on the technology buzzword theme, but if there was one common thread to the afternoon’s whirlwind tour of Seattle’s public and private life sciences work it was that which is new and unexpected — and a look to the future of healthcare.

View story >

Crafting a better T cell for immunotherapy

New technology, not yet tested in humans, aims to reduce patients’ waiting time, increase potency of T-cell therapy

Feb. 22, 2016 | By Rachel Tompa / Fred Hutch News Service

Fred Hutch immunotherapy researchers Drs. Stan Riddell and Steven Liu have collaborated with others to devise a new approach to T-cell therapy that could both speed up and boost the effectiveness of the experimental new treatment.

View story >

Five Consortium teams win pilot grants

Cancer Center Support Grant Pilot Awards fund new research directions and collaborations

May 7, 2012 | By Dr. Marion Dorer

Five collaborative teams within the Fred Hutchinson/University of Washington Cancer Consortium have received Cancer Center Support Grant (CCSG) Pilot Awards for 2012. The pilot grants are presented every year to fund new Consortium research directions and collaborations.

View story >

Greenberg receives immunotherapy award

Clinical Research Division's Philip Greenberg honored for pioneering work to bring adoptive T-cell therapy from bench to bedside

Sept. 26, 2011

Dr. Philip Greenberg, head of the Fred Hutchinson Cancer Research Center’s Immunology Program in the Clinical Research Division, is the joint recipient of the 2011 William B. Coley Award for Distinguished Research in Tumor Immunology for his pioneering research in adoptive T-cell therapy.

View story >

Yee Lab’s Pollack wins $300,000 sarcoma award

Sarcoma Alliance for Research through Collaboration boosts Seth Pollack’s adoptive T-cell therapy research for bone and tissue cancers

May 16, 2011 | By Colleen Steelquist

Dr. Seth Pollack, a postdoctoral fellow in the Fred Hutchinson Cancer Research Center Clinical Research Division’s Yee Lab, has been awarded a three-year, $300,000 career development award from the Sarcoma Alliance for Research through Collaboration for his efforts in developing adoptive T-cell therapy for sarcomas—cancers of the bone and connective tissues.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.